DE3586826D1 - Cdna-klone, kodierend fuer peptide mit der wirksamkeit eines menschlichen granulocyte-, makrophage- und eosinophilzellenwachstumsfaktors. - Google Patents

Cdna-klone, kodierend fuer peptide mit der wirksamkeit eines menschlichen granulocyte-, makrophage- und eosinophilzellenwachstumsfaktors.

Info

Publication number
DE3586826D1
DE3586826D1 DE8585906001T DE3586826T DE3586826D1 DE 3586826 D1 DE3586826 D1 DE 3586826D1 DE 8585906001 T DE8585906001 T DE 8585906001T DE 3586826 T DE3586826 T DE 3586826T DE 3586826 D1 DE3586826 D1 DE 3586826D1
Authority
DE
Germany
Prior art keywords
cdna
growth factor
macrophage
human granulocyte
eosinophile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8585906001T
Other languages
English (en)
Other versions
DE3586826T2 (de
Inventor
Takashi Yokota
Don Lee
Maye Rennick
Ken-Ichi Arai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Biotech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Biotech Corp filed Critical Schering Biotech Corp
Application granted granted Critical
Publication of DE3586826D1 publication Critical patent/DE3586826D1/de
Publication of DE3586826T2 publication Critical patent/DE3586826T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/53Colony-stimulating factor [CSF]
    • C07K14/535Granulocyte CSF; Granulocyte-macrophage CSF
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Saccharide Compounds (AREA)
DE8585906001T 1984-11-20 1985-11-18 Cdna-klone, kodierend fuer peptide mit der wirksamkeit eines menschlichen granulocyte-, makrophage- und eosinophilzellenwachstumsfaktors. Expired - Lifetime DE3586826T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67389884A 1984-11-20 1984-11-20
PCT/US1985/002250 WO1986003225A1 (en) 1984-11-20 1985-11-18 cDNA CLONES CODING FOR POLYPEPTIDES EXHIBITING HUMAN GRANULOCYTE MACROPHAGE AND EOSINOPHIL CELLULAR GROWTH FACTOR ACTIVITY

Publications (2)

Publication Number Publication Date
DE3586826D1 true DE3586826D1 (de) 1992-12-17
DE3586826T2 DE3586826T2 (de) 1993-03-25

Family

ID=24704538

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585906001T Expired - Lifetime DE3586826T2 (de) 1984-11-20 1985-11-18 Cdna-klone, kodierend fuer peptide mit der wirksamkeit eines menschlichen granulocyte-, makrophage- und eosinophilzellenwachstumsfaktors.

Country Status (26)

Country Link
EP (1) EP0202300B1 (de)
JP (1) JP3038348B2 (de)
KR (1) KR920003822B1 (de)
CN (3) CN1031465C (de)
AT (1) ATE82321T1 (de)
AU (1) AU608741B2 (de)
BG (1) BG60840B2 (de)
DE (1) DE3586826T2 (de)
DK (1) DK174598B1 (de)
ES (1) ES8705470A1 (de)
FI (1) FI103986B1 (de)
GR (1) GR852786B (de)
HK (1) HK6096A (de)
HU (1) HU213226B (de)
IE (1) IE59581B1 (de)
IL (1) IL77080A (de)
LU (1) LU88360I2 (de)
MX (1) MX9203397A (de)
MY (1) MY101971A (de)
NL (1) NL930120I2 (de)
NO (1) NO862903L (de)
NZ (1) NZ214225A (de)
OA (1) OA08671A (de)
PT (1) PT81513B (de)
WO (1) WO1986003225A1 (de)
ZA (1) ZA858833B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU594014B2 (en) * 1984-03-21 1990-03-01 Research Corporation Technologies, Inc. Recombinant DNA molecules
UA29377C2 (uk) * 1984-09-19 2000-11-15 Новартіс Аг Спосіб отримання білка з активністю колонієстимулювального фактора гранулоцитів та макрофагів(gm-csf) приматів
AU588819B2 (en) * 1984-10-29 1989-09-28 Immunex Corporation Cloning of human granulocyte-macrophage colony stimulating factor gene
ZA856108B (en) * 1984-10-29 1986-10-29 Immunex Corp Cloning of human granulocyte-macrophage colony simulating factor gene
US5078996A (en) * 1985-08-16 1992-01-07 Immunex Corporation Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
WO1987002060A1 (en) * 1985-10-03 1987-04-09 Biogen N.V. Human granulocyte-macrophage colony stimulating factor-like polypeptides and processes for producing them in high yields in microbial cells
JPH0618778B2 (ja) * 1985-10-04 1994-03-16 中外製薬株式会社 白血球減少症治療剤
US5298603A (en) * 1985-12-21 1994-03-29 Hoechst Aktiengesellschaft GM-CSF protein, its derivatives, the preparation of proteins of this type, and their use
DE3545568A1 (de) * 1985-12-21 1987-07-16 Hoechst Ag Gm-csf-protein, seine derivate, herstellung solcher proteine und ihre verwendung
JP2583770B2 (ja) * 1986-09-17 1997-02-19 大塚製薬株式会社 遺伝子
EP0276846A3 (de) * 1987-01-29 1989-07-26 Zymogenetics, Inc. Derivate des koloniestimulierenden Faktors
JPS6420097A (en) * 1987-03-02 1989-01-24 Sumitomo Chemical Co Human granulocyte-macrophage colony stimulating factor
AU621051B2 (en) * 1987-04-28 1992-03-05 Amgen, Inc. Method for purifying granulocyte-macrophage colony stimulating factor
IE63514B1 (en) * 1987-07-17 1995-05-03 Schering Biotech Corp Expression vectors for the production of human granulocyte-macrophage colony stimulation factor in a mammalian cell host
AU626530B2 (en) * 1987-07-17 1992-08-06 Schering Biotech Corporation Human granulocyte-macrophage colony stimulating factor and muteins thereof
GB2212159B (en) * 1987-11-13 1992-01-22 British Bio Technology Synthetic gene for human granulocyte/macrophage colony stimulating factor.
JPH03503897A (ja) * 1988-04-21 1991-08-29 メドベット・サイエンス・プロプライアテリー・リミテッド ひとgm‐csf変異形類
US5109119A (en) * 1989-06-06 1992-04-28 Schering Corporation Crystalline r-h-gm-csf and method
KR100448021B1 (ko) * 2001-12-28 2004-09-08 크레아젠 주식회사 마우스 과립구 대식세포 콜로니 촉진인자 발현벡터 pGM-CSF로 형질전환된 대장균 및 상기 마우스 과립구 대식세포 콜로니 촉진인자의 대량생산방법
CA2497554A1 (en) * 2002-09-20 2004-04-01 Dendreon Corporation Immunotherapeutic compositions and methods for the treatment of moderately to well-differentiated cancers

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4438032A (en) * 1981-01-30 1984-03-20 The Regents Of The University Of California Unique T-lymphocyte line and products derived therefrom
AU594014B2 (en) * 1984-03-21 1990-03-01 Research Corporation Technologies, Inc. Recombinant DNA molecules
AU599572B2 (en) * 1984-07-06 1990-07-26 Novartis Ag Lymphokine production and purification
ZA856108B (en) * 1984-10-29 1986-10-29 Immunex Corp Cloning of human granulocyte-macrophage colony simulating factor gene
AU588819B2 (en) * 1984-10-29 1989-09-28 Immunex Corporation Cloning of human granulocyte-macrophage colony stimulating factor gene

Also Published As

Publication number Publication date
MX9203397A (es) 1992-07-01
OA08671A (en) 1989-03-31
JPS62501259A (ja) 1987-05-21
CN1045539C (zh) 1999-10-13
NL930120I1 (nl) 1993-11-01
JP3038348B2 (ja) 2000-05-08
NO862903L (no) 1986-09-18
IE852889L (en) 1986-05-20
IE59581B1 (en) 1994-03-09
CN1086543A (zh) 1994-05-11
FI103986B (fi) 1999-10-29
BG60840B2 (bg) 1996-04-30
PT81513A (en) 1985-12-01
DK174598B1 (da) 2003-07-14
DE3586826T2 (de) 1993-03-25
FI862674A (fi) 1986-06-24
IL77080A0 (en) 1986-04-29
ES8705470A1 (es) 1987-05-01
NL930120I2 (nl) 1994-07-01
ES548998A0 (es) 1987-05-01
CN1020473C (zh) 1993-05-05
NO862903D0 (no) 1986-07-18
AU608741B2 (en) 1991-04-18
CN85109132A (zh) 1986-12-03
DK345286D0 (da) 1986-07-21
LU88360I2 (fr) 1994-05-04
IL77080A (en) 1998-02-08
FI862674A0 (fi) 1986-06-24
HK6096A (en) 1996-01-19
HUT40464A (en) 1986-12-28
FI103986B1 (fi) 1999-10-29
NZ214225A (en) 1991-05-28
DK345286A (da) 1986-07-21
ZA858833B (en) 1986-06-25
ATE82321T1 (de) 1992-11-15
GR852786B (de) 1986-03-20
CN1031465C (zh) 1996-04-03
HU213226B (en) 1997-03-28
AU5196386A (en) 1986-06-18
EP0202300A1 (de) 1986-11-26
PT81513B (pt) 1988-03-03
KR920003822B1 (ko) 1992-05-15
KR860700359A (ko) 1986-10-06
EP0202300B1 (de) 1992-11-11
MY101971A (en) 1992-02-29
WO1986003225A1 (en) 1986-06-05

Similar Documents

Publication Publication Date Title
DE3586826D1 (de) Cdna-klone, kodierend fuer peptide mit der wirksamkeit eines menschlichen granulocyte-, makrophage- und eosinophilzellenwachstumsfaktors.
DE3485652D1 (de) Cdna-klone, codierend fuer polypeptide mit der wirksamkeit eines nicht-zellinienspezifischen wachstumsfaktors (multi-csf) und/oder mastzellenwachstumsfaktors (mcgf).
EP0722461A4 (de) Expression eines fusionspolypeptides, das ohne leadersequenz aus dem cytoplasma transportiert wird
IL77081A0 (en) Cloned human erythropoietin genes and products thereof
KR900016465A (ko) 사람의 macif 활성을 지닌 단백질을 암호화하는 유전자, 이 유전자를 함유하는 발현벡터, 형질전환 세포 및 사람 macif활성을 갖는 단백질
ATE175719T1 (de) Epididymis-spezifische polypeptide und deren verwendung

Legal Events

Date Code Title Description
V448 Application of spc

Free format text: PRODUCT NAME: MOLGRAMOSTIM; REGISTRATION NO/DATE: 26094.00.00, 26094.01.00, 26094.02.00, 26094.03.00, 26094.04.00, 26094.05.00; 19930426

Spc suppl protection certif: 193 75 109

Filing date: 19930807

8364 No opposition during term of opposition
V484 Delivery of the decision of grant

Free format text: PRODUCT NAME: MOLGRAMOSTIM; REGISTRATION NO/DATE: 26094.00.00, 26094.01.00, 26094.02.00, 26094.03.00, 26094.04.00, 26094.05.00; 19930426

Spc suppl protection certif: 193 75 109

Filing date: 19930807

V457 Spc granted

Free format text: PRODUCT NAME: MOLGRAMOSTIM; REGISTRATION NO/DATE: 26094.00.00, 26094.01.00, 26094.02.00, 26094.03.00, 26094.04.00, 26094.05.00; 19930426

Spc suppl protection certif: 193 75 109

Filing date: 19930807

8327 Change in the person/name/address of the patent owner

Owner name: SCHERING CORP., KENILWORTH, N.J., US

V465 Spc lapsed due to nonpayment of the annual fee

Free format text: PRODUCT NAME: MOLGRAMOSTIM; REGISTRATION NO/DATE: 26094.00.00, 26094.01.00, 26094.02.00, 26094.03.00, 26094.04.00, 26094.05.00; 19930426

Spc suppl protection certif: 193 75 109

Filing date: 19930807